世界の後天性再生不良性貧血市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Acquired Aplastic Anemia Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0028
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、後天性再生不良性貧血のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（診断、治療）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・後天性再生不良性貧血の市場動向
・企業の競争状況、市場シェア
・後天性再生不良性貧血の種類別市場規模（診断、治療）
・後天性再生不良性貧血の用途別市場規模（病院、クリニック、その他）
・後天性再生不良性貧血の北米市場規模2016-2027（アメリカ、カナダ）
・後天性再生不良性貧血のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・後天性再生不良性貧血のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・後天性再生不良性貧血の中南米市場規模2016-2027（メキシコ、ブラジル）
・後天性再生不良性貧血の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Bayer、Novo Nordisk、Takeda、SOBI、Octapharma、CSL Limited、Amgen、GlaxoSmithKline、Bluebird bio）
・結論

Acquired aplastic anemia is a rare, serious blood disorder, due to failure of the bone marrow failure to produce blood cells. Bone marrow is the spongy substance found in the center of the bones of the body, in adults mainly the spine, pelvis, and large bones of the legs.

Market Analysis and Insights: Global Acquired Aplastic Anemia Market
The global Acquired Aplastic Anemia market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acquired Aplastic Anemia market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acquired Aplastic Anemia market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acquired Aplastic Anemia market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acquired Aplastic Anemia market.

Global Acquired Aplastic Anemia Scope and Market Size
Acquired Aplastic Anemia market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acquired Aplastic Anemia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Diagnosis
Treatment

Segment by Application
Hospitals
Clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Bayer
Novo Nordisk
Takeda
SOBI
Octapharma
CSL Limited
Amgen
GlaxoSmithKline

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acquired Aplastic Anemia Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diagnosis
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Acquired Aplastic Anemia Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acquired Aplastic Anemia Market Perspective (2016-2027)
2.2 Acquired Aplastic Anemia Growth Trends by Regions
2.2.1 Acquired Aplastic Anemia Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acquired Aplastic Anemia Historic Market Share by Regions (2016-2021)
2.2.3 Acquired Aplastic Anemia Forecasted Market Size by Regions (2022-2027)
2.3 Acquired Aplastic Anemia Industry Dynamic
2.3.1 Acquired Aplastic Anemia Market Trends
2.3.2 Acquired Aplastic Anemia Market Drivers
2.3.3 Acquired Aplastic Anemia Market Challenges
2.3.4 Acquired Aplastic Anemia Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acquired Aplastic Anemia Players by Revenue
3.1.1 Global Top Acquired Aplastic Anemia Players by Revenue (2016-2021)
3.1.2 Global Acquired Aplastic Anemia Revenue Market Share by Players (2016-2021)
3.2 Global Acquired Aplastic Anemia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acquired Aplastic Anemia Revenue
3.4 Global Acquired Aplastic Anemia Market Concentration Ratio
3.4.1 Global Acquired Aplastic Anemia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acquired Aplastic Anemia Revenue in 2020
3.5 Acquired Aplastic Anemia Key Players Head office and Area Served
3.6 Key Players Acquired Aplastic Anemia Product Solution and Service
3.7 Date of Enter into Acquired Aplastic Anemia Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acquired Aplastic Anemia Breakdown Data by Type
4.1 Global Acquired Aplastic Anemia Historic Market Size by Type (2016-2021)
4.2 Global Acquired Aplastic Anemia Forecasted Market Size by Type (2022-2027)

5 Acquired Aplastic Anemia Breakdown Data by Application
5.1 Global Acquired Aplastic Anemia Historic Market Size by Application (2016-2021)
5.2 Global Acquired Aplastic Anemia Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acquired Aplastic Anemia Market Size (2016-2027)
6.2 North America Acquired Aplastic Anemia Market Size by Type
6.2.1 North America Acquired Aplastic Anemia Market Size by Type (2016-2021)
6.2.2 North America Acquired Aplastic Anemia Market Size by Type (2022-2027)
6.2.3 North America Acquired Aplastic Anemia Market Size by Type (2016-2027)
6.3 North America Acquired Aplastic Anemia Market Size by Application
6.3.1 North America Acquired Aplastic Anemia Market Size by Application (2016-2021)
6.3.2 North America Acquired Aplastic Anemia Market Size by Application (2022-2027)
6.3.3 North America Acquired Aplastic Anemia Market Size by Application (2016-2027)
6.4 North America Acquired Aplastic Anemia Market Size by Country
6.4.1 North America Acquired Aplastic Anemia Market Size by Country (2016-2021)
6.4.2 North America Acquired Aplastic Anemia Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Acquired Aplastic Anemia Market Size (2016-2027)
7.2 Europe Acquired Aplastic Anemia Market Size by Type
7.2.1 Europe Acquired Aplastic Anemia Market Size by Type (2016-2021)
7.2.2 Europe Acquired Aplastic Anemia Market Size by Type (2022-2027)
7.2.3 Europe Acquired Aplastic Anemia Market Size by Type (2016-2027)
7.3 Europe Acquired Aplastic Anemia Market Size by Application
7.3.1 Europe Acquired Aplastic Anemia Market Size by Application (2016-2021)
7.3.2 Europe Acquired Aplastic Anemia Market Size by Application (2022-2027)
7.3.3 Europe Acquired Aplastic Anemia Market Size by Application (2016-2027)
7.4 Europe Acquired Aplastic Anemia Market Size by Country
7.4.1 Europe Acquired Aplastic Anemia Market Size by Country (2016-2021)
7.4.2 Europe Acquired Aplastic Anemia Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acquired Aplastic Anemia Market Size (2016-2027)
8.2 Asia-Pacific Acquired Aplastic Anemia Market Size by Type
8.2.1 Asia-Pacific Acquired Aplastic Anemia Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acquired Aplastic Anemia Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acquired Aplastic Anemia Market Size by Type (2016-2027)
8.3 Asia-Pacific Acquired Aplastic Anemia Market Size by Application
8.3.1 Asia-Pacific Acquired Aplastic Anemia Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acquired Aplastic Anemia Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acquired Aplastic Anemia Market Size by Application (2016-2027)
8.4 Asia-Pacific Acquired Aplastic Anemia Market Size by Region
8.4.1 Asia-Pacific Acquired Aplastic Anemia Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acquired Aplastic Anemia Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acquired Aplastic Anemia Market Size (2016-2027)
9.2 Latin America Acquired Aplastic Anemia Market Size by Type
9.2.1 Latin America Acquired Aplastic Anemia Market Size by Type (2016-2021)
9.2.2 Latin America Acquired Aplastic Anemia Market Size by Type (2022-2027)
9.2.3 Latin America Acquired Aplastic Anemia Market Size by Type (2016-2027)
9.3 Latin America Acquired Aplastic Anemia Market Size by Application
9.3.1 Latin America Acquired Aplastic Anemia Market Size by Application (2016-2021)
9.3.2 Latin America Acquired Aplastic Anemia Market Size by Application (2022-2027)
9.3.3 Latin America Acquired Aplastic Anemia Market Size by Application (2016-2027)
9.4 Latin America Acquired Aplastic Anemia Market Size by Country
9.4.1 Latin America Acquired Aplastic Anemia Market Size by Country (2016-2021)
9.4.2 Latin America Acquired Aplastic Anemia Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acquired Aplastic Anemia Market Size (2016-2027)
10.2 Middle East & Africa Acquired Aplastic Anemia Market Size by Type
10.2.1 Middle East & Africa Acquired Aplastic Anemia Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acquired Aplastic Anemia Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acquired Aplastic Anemia Market Size by Type (2016-2027)
10.3 Middle East & Africa Acquired Aplastic Anemia Market Size by Application
10.3.1 Middle East & Africa Acquired Aplastic Anemia Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acquired Aplastic Anemia Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acquired Aplastic Anemia Market Size by Application (2016-2027)
10.4 Middle East & Africa Acquired Aplastic Anemia Market Size by Country
10.4.1 Middle East & Africa Acquired Aplastic Anemia Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acquired Aplastic Anemia Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Acquired Aplastic Anemia Introduction
11.1.4 Pfizer Revenue in Acquired Aplastic Anemia Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Acquired Aplastic Anemia Introduction
11.2.4 Bayer Revenue in Acquired Aplastic Anemia Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Acquired Aplastic Anemia Introduction
11.3.4 Novo Nordisk Revenue in Acquired Aplastic Anemia Business (2016-2021)
11.3.5 Novo Nordisk Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Acquired Aplastic Anemia Introduction
11.4.4 Takeda Revenue in Acquired Aplastic Anemia Business (2016-2021)
11.4.5 Takeda Recent Development
11.5 SOBI
11.5.1 SOBI Company Details
11.5.2 SOBI Business Overview
11.5.3 SOBI Acquired Aplastic Anemia Introduction
11.5.4 SOBI Revenue in Acquired Aplastic Anemia Business (2016-2021)
11.5.5 SOBI Recent Development
11.6 Octapharma
11.6.1 Octapharma Company Details
11.6.2 Octapharma Business Overview
11.6.3 Octapharma Acquired Aplastic Anemia Introduction
11.6.4 Octapharma Revenue in Acquired Aplastic Anemia Business (2016-2021)
11.6.5 Octapharma Recent Development
11.7 CSL Limited
11.7.1 CSL Limited Company Details
11.7.2 CSL Limited Business Overview
11.7.3 CSL Limited Acquired Aplastic Anemia Introduction
11.7.4 CSL Limited Revenue in Acquired Aplastic Anemia Business (2016-2021)
11.7.5 CSL Limited Recent Development
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Amgen Business Overview
11.8.3 Amgen Acquired Aplastic Anemia Introduction
11.8.4 Amgen Revenue in Acquired Aplastic Anemia Business (2016-2021)
11.8.5 Amgen Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Details
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Acquired Aplastic Anemia Introduction
11.9.4 GlaxoSmithKline Revenue in Acquired Aplastic Anemia Business (2016-2021)
11.9.5 GlaxoSmithKline Recent Development
11.10 Bluebird bio
11.10.1 Bluebird bio Company Details
11.10.2 Bluebird bio Business Overview
11.10.3 Bluebird bio Acquired Aplastic Anemia Introduction
11.10.4 Bluebird bio Revenue in Acquired Aplastic Anemia Business (2016-2021)
11.10.5 Bluebird bio Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acquired Aplastic Anemia Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Diagnosis
Table 3. Key Players of Treatment
Table 4. Global Acquired Aplastic Anemia Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Acquired Aplastic Anemia Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Acquired Aplastic Anemia Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Acquired Aplastic Anemia Market Share by Regions (2016-2021)
Table 8. Global Acquired Aplastic Anemia Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Acquired Aplastic Anemia Market Share by Regions (2022-2027)
Table 10. Acquired Aplastic Anemia Market Trends
Table 11. Acquired Aplastic Anemia Market Drivers
Table 12. Acquired Aplastic Anemia Market Challenges
Table 13. Acquired Aplastic Anemia Market Restraints
Table 14. Global Acquired Aplastic Anemia Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Acquired Aplastic Anemia Market Share by Players (2016-2021)
Table 16. Global Top Acquired Aplastic Anemia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acquired Aplastic Anemia as of 2020)
Table 17. Ranking of Global Top Acquired Aplastic Anemia Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Acquired Aplastic Anemia Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Acquired Aplastic Anemia Product Solution and Service
Table 21. Date of Enter into Acquired Aplastic Anemia Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Acquired Aplastic Anemia Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Acquired Aplastic Anemia Revenue Market Share by Type (2016-2021)
Table 25. Global Acquired Aplastic Anemia Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Acquired Aplastic Anemia Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Acquired Aplastic Anemia Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Acquired Aplastic Anemia Revenue Market Share by Application (2016-2021)
Table 29. Global Acquired Aplastic Anemia Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Acquired Aplastic Anemia Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Acquired Aplastic Anemia Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Acquired Aplastic Anemia Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Acquired Aplastic Anemia Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Acquired Aplastic Anemia Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Acquired Aplastic Anemia Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Acquired Aplastic Anemia Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Acquired Aplastic Anemia Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Acquired Aplastic Anemia Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Acquired Aplastic Anemia Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Acquired Aplastic Anemia Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Acquired Aplastic Anemia Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Acquired Aplastic Anemia Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Acquired Aplastic Anemia Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Acquired Aplastic Anemia Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Acquired Aplastic Anemia Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Acquired Aplastic Anemia Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Acquired Aplastic Anemia Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Acquired Aplastic Anemia Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Acquired Aplastic Anemia Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Acquired Aplastic Anemia Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Acquired Aplastic Anemia Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Acquired Aplastic Anemia Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Acquired Aplastic Anemia Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Acquired Aplastic Anemia Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Acquired Aplastic Anemia Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Acquired Aplastic Anemia Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Acquired Aplastic Anemia Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Acquired Aplastic Anemia Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Acquired Aplastic Anemia Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Acquired Aplastic Anemia Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Acquired Aplastic Anemia Product
Table 64. Pfizer Revenue in Acquired Aplastic Anemia Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Bayer Company Details
Table 67. Bayer Business Overview
Table 68. Bayer Acquired Aplastic Anemia Product
Table 69. Bayer Revenue in Acquired Aplastic Anemia Business (2016-2021) & (US$ Million)
Table 70. Bayer Recent Development
Table 71. Novo Nordisk Company Details
Table 72. Novo Nordisk Business Overview
Table 73. Novo Nordisk Acquired Aplastic Anemia Product
Table 74. Novo Nordisk Revenue in Acquired Aplastic Anemia Business (2016-2021) & (US$ Million)
Table 75. Novo Nordisk Recent Development
Table 76. Takeda Company Details
Table 77. Takeda Business Overview
Table 78. Takeda Acquired Aplastic Anemia Product
Table 79. Takeda Revenue in Acquired Aplastic Anemia Business (2016-2021) & (US$ Million)
Table 80. Takeda Recent Development
Table 81. SOBI Company Details
Table 82. SOBI Business Overview
Table 83. SOBI Acquired Aplastic Anemia Product
Table 84. SOBI Revenue in Acquired Aplastic Anemia Business (2016-2021) & (US$ Million)
Table 85. SOBI Recent Development
Table 86. Octapharma Company Details
Table 87. Octapharma Business Overview
Table 88. Octapharma Acquired Aplastic Anemia Product
Table 89. Octapharma Revenue in Acquired Aplastic Anemia Business (2016-2021) & (US$ Million)
Table 90. Octapharma Recent Development
Table 91. CSL Limited Company Details
Table 92. CSL Limited Business Overview
Table 93. CSL Limited Acquired Aplastic Anemia Product
Table 94. CSL Limited Revenue in Acquired Aplastic Anemia Business (2016-2021) & (US$ Million)
Table 95. CSL Limited Recent Development
Table 96. Amgen Company Details
Table 97. Amgen Business Overview
Table 98. Amgen Revenue in Acquired Aplastic Anemia Business (2016-2021) & (US$ Million)
Table 99. Amgen Recent Development
Table 100. GlaxoSmithKline Company Details
Table 101. GlaxoSmithKline Business Overview
Table 102. GlaxoSmithKline Acquired Aplastic Anemia Product
Table 103. GlaxoSmithKline Revenue in Acquired Aplastic Anemia Business (2016-2021) & (US$ Million)
Table 104. GlaxoSmithKline Recent Development
Table 105. Bluebird bio Company Details
Table 106. Bluebird bio Business Overview
Table 107. Bluebird bio Acquired Aplastic Anemia Product
Table 108. Bluebird bio Revenue in Acquired Aplastic Anemia Business (2016-2021) & (US$ Million)
Table 109. Bluebird bio Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acquired Aplastic Anemia Market Share by Type: 2020 VS 2027
Figure 2. Diagnosis Features
Figure 3. Treatment Features
Figure 4. Global Acquired Aplastic Anemia Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Other Case Studies
Figure 8. Acquired Aplastic Anemia Report Years Considered
Figure 9. Global Acquired Aplastic Anemia Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Acquired Aplastic Anemia Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Acquired Aplastic Anemia Market Share by Regions: 2020 VS 2027
Figure 12. Global Acquired Aplastic Anemia Market Share by Regions (2022-2027)
Figure 13. Global Acquired Aplastic Anemia Market Share by Players in 2020
Figure 14. Global Top Acquired Aplastic Anemia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acquired Aplastic Anemia as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Acquired Aplastic Anemia Revenue in 2020
Figure 16. Global Acquired Aplastic Anemia Revenue Market Share by Type (2016-2021)
Figure 17. Global Acquired Aplastic Anemia Revenue Market Share by Type (2022-2027)
Figure 18. North America Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Acquired Aplastic Anemia Market Share by Type (2016-2027)
Figure 20. North America Acquired Aplastic Anemia Market Share by Application (2016-2027)
Figure 21. North America Acquired Aplastic Anemia Market Share by Country (2016-2027)
Figure 22. United States Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Acquired Aplastic Anemia Market Share by Type (2016-2027)
Figure 26. Europe Acquired Aplastic Anemia Market Share by Application (2016-2027)
Figure 27. Europe Acquired Aplastic Anemia Market Share by Country (2016-2027)
Figure 28. Germany Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Acquired Aplastic Anemia Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Acquired Aplastic Anemia Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Acquired Aplastic Anemia Market Share by Region (2016-2027)
Figure 38. China Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Acquired Aplastic Anemia Market Share by Type (2016-2027)
Figure 46. Latin America Acquired Aplastic Anemia Market Share by Application (2016-2027)
Figure 47. Latin America Acquired Aplastic Anemia Market Share by Country (2016-2027)
Figure 48. Mexico Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Acquired Aplastic Anemia Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Acquired Aplastic Anemia Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Acquired Aplastic Anemia Market Share by Country (2016-2027)
Figure 54. Turkey Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Acquired Aplastic Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Acquired Aplastic Anemia Business (2016-2021)
Figure 58. Bayer Revenue Growth Rate in Acquired Aplastic Anemia Business (2016-2021)
Figure 59. Novo Nordisk Revenue Growth Rate in Acquired Aplastic Anemia Business (2016-2021)
Figure 60. Takeda Revenue Growth Rate in Acquired Aplastic Anemia Business (2016-2021)
Figure 61. SOBI Revenue Growth Rate in Acquired Aplastic Anemia Business (2016-2021)
Figure 62. Octapharma Revenue Growth Rate in Acquired Aplastic Anemia Business (2016-2021)
Figure 63. CSL Limited Revenue Growth Rate in Acquired Aplastic Anemia Business (2016-2021)
Figure 64. Amgen Revenue Growth Rate in Acquired Aplastic Anemia Business (2016-2021)
Figure 65. GlaxoSmithKline Revenue Growth Rate in Acquired Aplastic Anemia Business (2016-2021)
Figure 66. Bluebird bio Revenue Growth Rate in Acquired Aplastic Anemia Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界の後天性再生不良性貧血市場規模・現状・予測（2021年-2027年）

Global Acquired Aplastic Anemia Market Size, Status and Forecast 2021-2027
QYR2104Z0028 2021年4月 99Pages
QYResearch社発行の本調査資料では、後天性再生不良性貧血のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（診断、治療）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、...

世界の後天性再生不良性貧血市場 2021：企業別、地域別、種類・用途別

Global Acquired Aplastic Anemia Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z00294 2021年4月 101Pages
当調査資料では、後天性再生不良性貧血のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。後天性再生不良性貧血の種類別市場規模（診断、治療）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、...

世界の貧血治療薬市場規模・現状・予測（2021年-2027年）

Global Anemia Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z0322 2021年4月 93Pages
QYResearch社発行の本調査資料では、貧血治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（鉄欠乏性貧血、慢性腎臓病関連貧血、鎌状赤血球貧血、再生不良性貧血）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年）

Global Acquired hemophilia A Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0029 2021年4月 97Pages
QYResearch社発行の本調査資料では、後天性血友病A治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（200IU、250IU）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界の貧血治療市場規模・現状・予測（2021年-2027年）

Global Anemia Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z0323 2021年4月 99Pages
QYResearch社発行の本調査資料では、貧血治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（鉄欠乏性貧血、鎌状赤血球貧血、悪性貧血、溶血性貧血）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界の貧血治療市場規模・現状・予測（2021年-2027年）

世界の院内感染症（HAI）診断市場規模・現状・予測（2021年-2027年）

Global Hospital Acquired Infections (HAI) Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z2905 2021年4月 96Pages
QYResearch社発行の本調査資料では、院内感染症（HAI）診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（分子診断検査、その他の体外診断検査）、用途別市場規模（菌血症（BSI）、尿路感染症（UTI）、手術部位感染症（SSI）、肺炎、そ...

世界の院内肺炎予防市場規模・現状・予測（2021年-2027年）

Global Hospital-Acquired Pneumonia Prevention Market Size, Status and Forecast 2021-2027
QYR2104Z2921 2021年4月 94Pages
QYResearch社発行の本調査資料では、院内肺炎予防のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（オーラルケアキット、歯ブラシ、綿棒、保湿剤、うがい薬、吸引具）、用途別市場規模（病院、リハビリセンター、在宅介護施設）、主要地域別市場規模（...

世界の化学療法誘発性貧血市場規模・現状・予測（2021年-2027年）

Global Chemotherapy Induced Anemia Market Size, Status and Forecast 2021-2027
QYR2104Z1272 2021年4月 90Pages
QYResearch社発行の本調査資料では、化学療法誘発性貧血のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（軽度貧血、中等度貧血、重度貧血、致死的貧血）、用途別市場規模（病院、外来手術センター、専門クリニック、がん研究センター、がんリハビリセ...

世界の市中肺炎（CAP）市場規模・現状・予測（2021年-2027年）

Global Community Acquired Pneumonia (CAP) Market Size, Status and Forecast 2021-2027
QYR2104Z1495 2021年4月 91Pages
QYResearch社発行の本調査資料では、市中肺炎（CAP）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（胸部X線/X線撮影、喀痰グラム染色/培養、血液培養）、用途別市場規模（病院・クリニック、その他）、主要地域別市場規模（北米、アメリカ、...

世界の後天性再生不良性貧血市場規模・現状・予測（2021年-2027年） Acquired aplastic anemia is a rare, serious blood disorder, due to failure of the bone marrow failure to produce blood cells. Bone marrow is the spongy substance found in the center of the bones of the body, in adults mainly the spine, pelvis, and large bones of the legs. Market Analysis and Insight…
世界の後天性再生不良性貧血市場 2021：企業別、地域別、種類・用途別 The Acquired Aplastic Anemia market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年） ELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer. Market Analysis and Insights: Global Acquired hemophilia A Treatment Market The global Acquired hemophilia A Treatment market size is projected to reach US$ X…
世界の院内肺炎予防市場規模・現状・予測（2021年-2027年） HAP is defined as a lower respiratory infection, which does not incubate at the time of hospital admission but presents clinically 2 or more days after hospitalization.Incidence of HAP is more prevalent in the medical and surgical Intensive Care Units, and results in additional cost to the healthcar…
世界の院内感染症（HAI）診断市場規模・現状・予測（2021年-2027年） Patients may catch infections during they are in the hospital, the hospital acquired infection test is used to diagnose those infections. The industry is anticipated to witness a significant growth in the next few years. One of the key factors driving industry growth is the rising geriatric populati…